ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 0660

Improving the Gout Flare Chart Review Using Linked Claims-EHR Data

Kazuki Yoshida, Tianrun Cai, Lily G. Bessette, Erin Kim, Su Been Lee, Luke E. Zabotka, Alec Sun, Jun Liu, DH Solomon, Katherine Liao and Seoyoung Kim, Brigham and Women's Hospital, Boston, MA

Meeting: ACR Convergence 2021

Keywords: Administrative Data, Bioinformatics, EMR, gout

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I (0660–0682)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Recurrent gout flares are the most crucial outcome in studies of gout treatment. However, gout flares is challenging to identify in a large population because it is episodic with limited data to distinguish encounters for a gout flare vs routine follow-up for gout. The objective of this study was to determine whether integrating information extracted from the narrative notes from the electronic health record (EHR) data using natural language processing (NLP) can improve the efficiency for identifying gout glares over claims data alone.

Methods: The study population was defined by first linking Medicare claims data (2007-16) with EHR data from two tertiary care centers. Subjects with age≥65, ≥1 gout ICD9/10 code, and initiated the urate-lowering therapy (ULT; allopurinol or febuxostat) were included in the study. Chart reviews were performed on a random sample of the study population to create a gold standard set of notes describing gout flare. A list of terms related to gout flare was created informed by the chart review (Table 1). Terms were further mapped to concepts as defined by the Unified Medical Language System (UMLS). Narrative notes for all subjects were processed using NLP to identify all notes containing terms/concepts related to gout flare. Claims data were also used to segment notes by time period in two ways (claims time filter): (1) identify notes within the 12-month baseline before date of ULT initiation through ULT discontinuation; (2) notes occurring in months with ≥1 ICD9/10 gout code from claims within (1). We tested whether NLP and the application of temporally based claims-based rules could improve the prevalence of notes describing gout flares compared to ICD alone.

Results: A random sample of 69 patients with 10,845 notes was examined. NLP concepts representing signs and symptoms of a gout flare, e.g. redness, severe pain, differed the most among notes describing gout flares compared to those that were not (Table 2). After processing notes using NLP, 708 (6.5%) of 10,845 notes had concepts relevant to gout flare (Table 3); of the 708 notes, 24.4% described a gout flare. Applying claims time filter 1 alone to the 10,845 notes selected 2,198 (20%), of which 271 also had relevant NLP concepts. Claims time filter 2 selected 691 notes (6.4%), of which 169 also had relevant NLP concepts. Using a combination of NLP and claims time filter 2, which gave notes in months where an ICD9/10 gout code was used (nested within the 12-month baseline and during ULT use), resulted in 54% prevalence of gout flares among the selected notes.

Conclusion: Certain NLP concepts may be useful in discriminating notes describing gout flare among a population of subjects with gout on ULT therapy. The combination of NLP as well as the use of claims data with a time component, e.g., segmented by months, can assist in selecting relevant notes describing a gout flare. Together, these provide data for the development of a gout flare phenotyping algorithm with month-level precision.


Disclosures: K. Yoshida, None; T. Cai, None; L. Bessette, None; E. Kim, None; S. Lee, None; L. Zabotka, None; A. Sun, None; J. Liu, None; D. Solomon, Abbvie, 5, Amgen, 5, Genentech, 5; K. Liao, None; S. Kim, AbbVie, 5, Roche, 5, Pfizer, 5, Bristol-Myers Squibb, 5.

To cite this abstract in AMA style:

Yoshida K, Cai T, Bessette L, Kim E, Lee S, Zabotka L, Sun A, Liu J, Solomon D, Liao K, Kim S. Improving the Gout Flare Chart Review Using Linked Claims-EHR Data [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/improving-the-gout-flare-chart-review-using-linked-claims-ehr-data/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-the-gout-flare-chart-review-using-linked-claims-ehr-data/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology